Small molecule screening for inhibitors of the YopH phosphatase of Yersinia pseudotuberculosis

Advances in Experimental Medicine and Biology

Volumn 954, Issue , 2012, Pages 357-363

  Eriksson, Jonas ^a   Grundström, Christin ^a   Sauer Eriksson, A Elisabeth ^a   Sauer, Uwe H ^a   Wolf Watz, Hans ^a   Elofsson, Mikael ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE; YOPH PROTEIN, YERSINIA;

ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; YERSINIA PSEUDOTUBERCULOSIS;

BACTERIAL OUTER MEMBRANE PROTEINS; DRUG EVALUATION, PRECLINICAL; PROTEIN TYROSINE PHOSPHATASES; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84868160251     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3561-7_43     Document Type: Conference Paper

References (31)

1. Bahta M, Lountos GT, Dyas B et al (2011) Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar af fi nity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase. J Med Chem 54:2933-2943
2. Baron C (2009) Antivirulence drugs to target bacterial secretion systems. Curr Opin Microbiol 13:1-6
3. Bölin I, Wolf-Watz H (1988) The plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription. Mol Microbiol 2:237-245
4. Coan KE, Shoichet BK (2008) Stoichiometry and physical chemistry of promiscous aggregate-based inhibitors. J Am Chem Soc 130:9606-9612
5. Comeau AB, Critton DA, Page R et al (2010) A focused library of protein tyrosine phosphatase inhibitors. J Med Chem 53:6768-6772
6. Dahlgren MK, Kauppi AM, Olsson IM et al (2007) Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides, potent inhibitors of type III secretion in Yersinia. J Med Chem 50:6177-6188
7. Dahlgren MK, Öberg CT, Wallin EA et al (2010a) Synthesis of 2-(2-aminopyrimidine)-2,2-difluoroethanols as potential bioisosters of salicylidene acylhydrazides. Molecules 15:4423-4438
8. Dahlgren MK, Zetterström CE, Gylfe Å et al (2010b) Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gramnegative bacterium Yersinia. Bioorg Med Chem 18: 2686-2703
9. Galan JE, Wolf-Watz H (2006) Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573
10. Gee KR, Sun WC, Bhalgat MK et al (1999) Fluorogenic substrates based on fl uorinated umbelliferones for continuous assays of phosphatases and beta-galactosidases. Anal Biochem 273:41-48
11. Hillgren JM, Dahlgren MK, To TM et al (2010) Synthesis of [4-(2-hydroxyphenyl)thiazol-2-yl]methanones as potential bioisosteres of salicylidene acylhydrazides. Molecules 15:6019-6034
12. Huang Z, He Y, Zhang X et al (2010) Derivatives of salicylic acid as inhibitors of YopH in Yersinia pestis. Chem Biol Drug Des 76:85-99
13. Hueck CJ (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62:379-433
14. Juris SJ, Shao F, Dixon JE (2002) Yersinia effectors target mammalian signalling pathways. Cell Microbiol 4: 201-211
15. Kauppi AM, Nordfelth R, Hägglund U et al (2003a) Salicylanilides are potent inhibitors of type III secretion in Yersinia. Adv Exp Med Biol 529:97-100
16. Kauppi AM, Nordfelth R, Uvell H et al (2003b) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10:241-249
17. Kauppi AM, Andersson CD, Norberg HA et al (2007) Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylaminobenzanilides. Bioorg Med Chem 15:6994-7011
18. Keyser P, Elofsson M, Rosell S et al (2008) Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J Intern Med 264:17-29
19. Lee K, Boovanahalli SK, Nam KY et al (2005) Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett 15: 4037-4042
20. Leone M, Barile E, Vazquez J et al (2010) NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH. Chem Biol Drug Des 76:10-16
21. Liang F, Huang Z, Lee SY (2003) Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague. J Biol Chem 278:41734-41741
22. Liu F, Hakami RM, Dyas B et al (2010) A rapid oxime linker-based library approach to identi fi cation of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH. Bioorg Med Chem Lett 20:2813-2816
23. McCain DF, Wu L, Nickel P et al (2004) Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases. J Biol Chem 279:14713-14725
24. Michiels T, Cornelis G (1988) Nucleotide sequence and transcription analysis of yop51 from Yersinia enterocolitica W22703. Microb Pathog 5:449-459
25. Nordfelth R, Kauppi AM, Norberg HA et al (2005) Smallmolecule inhibitors speci fi cally targeting type III secretion. Infect Immun 73:3104-3114
26. Rosqvist R, Bölin I, Wolf-Watz H (1988) Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect Immun 56:2139-2143
27. Straley CS, Bowmer WS (1986) Virulence genes regulated at the transcriptional level by Ca 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun 51:445-454
28. Tautz L, Bruckner S, Sareth S et al (2005) Inhibition of Yersinia tyrosine phosphatase by furanyl salicylate compounds. J Biol Chem 280:9400-9408
29. Tierno MB, Johnston PA, Foster C et al (2007) Development and optimization of high-throughput in vitro protein phosphatase screening assays. Nat Protoc 2:1134-1144
30. Vazquez J, Tautz L, Ryan JJ et al (2007) Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors. J Med Chem 50:2137-2143
31. Zhang JH, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67-73